American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Matinas BioPharma Holdings, Inc. (MTNB)

$1.83 +10.24% NYSE: MTNB · 15-min delayed

BEDMINSTER, New Jersey
Public · NYSE: MTNB
2 employees

Visit website Follow

$1.5MMarket cap

$1.1MRevenue · FY2023

-$10.3MNet income

2Employees

MTNBNYSE

2014IPO

About Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NYSE: MTNB
Employees: 2
IPO date: Jul 21, 2014
Headquarters: 1545 ROUTE 206 SOUTH
BEDMINSTER, New Jersey 07921
Phone: 908-484-8805
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: MTNB NYSE
SEC CIK: 1582554
EIN: 463011414
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Matinas BioPharma Holdings, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/matinas-biopharma-holdings-inc/"><img src="https://americancompanies.com/badge/matinas-biopharma-holdings-inc.svg" alt="Matinas BioPharma Holdings, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Matinas BioPharma Holdings, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2023: $1.1M
Net income: -$10.3M
Total assets: $7.2M
Market cap: $1.5M

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: MTNB

$1.83 +10.24%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.52 $29.10

52-week range

Market cap: $1.5M
Shares outstanding: 845.1K
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jul 21, 2014

Matinas BioPharma Holdings, Inc. (MTNB) Stock Price

Reported a net loss of $10.3M in FY2023.
Trading 94% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Matinas BioPharma Holdings, Inc..

Write a review

Newsroom

News about Matinas BioPharma Holdings, Inc.

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards GlobeNewswire Inc. · 2026-09-04 · negative Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance GlobeNewswire Inc. · 2026-06-26 · negative Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program GlobeNewswire Inc. · 2024-06-24 Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin GlobeNewswire Inc. · 2024-06-13 New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024 GlobeNewswire Inc. · 2024-05-16 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update GlobeNewswire Inc. · 2024-05-09

News & sentiment via Polygon.io

FAQ

Matinas BioPharma Holdings, Inc.: frequently asked questions

Is Matinas BioPharma Holdings, Inc. an American company?

Matinas BioPharma Holdings, Inc. is a US-based company headquartered in Bedminster, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Matinas BioPharma Holdings, Inc. headquartered?

Matinas BioPharma Holdings, Inc. is headquartered in Bedminster, New Jersey, United States.

Is Matinas BioPharma Holdings, Inc. publicly traded?

Yes — Matinas BioPharma Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol MTNB on the NYSE.

What does Matinas BioPharma Holdings, Inc. do?

Matinas BioPharma Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore